Welcome to the team Megan, Ish and Georgina


Megan, Ish and Georgina are the latest cohort of Laboratory scientists to join us as we continue on our strategic growth journey that will see us become one of the world’s largest and most agile assay contract manufacturers.

In November of last year,  we announced our relocation into a new, purpose built manufacturing facility and our intention to double our workforce.  Our recruitment plans are well underway and we look forward to welcoming more new members of the Biofortuna team in the coming weeks.

The original press release is reproduced below:


Deeside, UK.  01 November 2021

Biotech firm looks to double in size as it invests in the future


UK biotech company, Biofortuna, has set out plans to double the size of its team after investing in new purpose built manufacturing facility in Deeside.


The company, which specialises in developing and manufacturing diagnostic tests for a wide range of conditions, expects to double its headcount from 34 to more than 60 over the next two years as result of its relocation which has more than doubled its manufacturing capacity and includes a class-leading, humidity-controlled clean room for manufacturing more than 10 million tests per week.


The new jobs will include roles across the whole business including assay development, manufacturing, project management and sales.


Biofortuna has particular expertise in assay stabilisation; techniques that enable diagnostic tests to be transported and stored at room temperature without the need for expensive and energy inefficient refrigeration and freezing.


Chief Executive Officer Dr Nick Ash said: “This multi-million-pound investment demonstrates our ambition and commitment to become the sector’s leading support specialist, helping our customers to accelerate their diagnostic development programmes from concept to commercialisation.”


Head of Sales Paul Williams added: “This facility will position Biofortuna as one of the leading outsourced providers of genomic services, custom assay development and contract manufacturing.”

Comments are closed.